Skip to content
Tuesday 18 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,763.18
+0.40%
DAX
26,194.81
-0.55%
CAC 40
8,528.01
-0.60%
STOXX 50
6,485.95
-0.68%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Friday 26 March 2021 3:56 pm  |  Updated:  Friday 26 March 2021 4:35 pm

Coronavirus latest updates: EU boosts vaccine supply; Norway halts Astrazeneca jab; London R rate rises

By: Poppy Wood

Add as a preferred source on Google
Government Talks Over Manchester Coronavirus Restrictions Resume

EU boosts production of Covid vaccines

The European Medicines Agency announced this afternoon that it has approved the use of two European factories to scale up the EU’s vaccine supply.

The Halix factory in the Netherlands has been cleared to produce doses of the Astrazeneca vaccine for the EU, while another in Marburg in Germany will produce supplies of the Pfizer vaccine.

It is unclear whether this will affect the UK’s supply of the Astrazeneca vaccine being produced at the same site in the Netherlands.

However, Boris Johnson signalled earlier this week that he was willing to compromise on Britain’s Dutch-made doses in a bid to avoid a total ban on vaccine exports out of the EU.

This latest move might have proven the ice pack for a long-running dispute between the UK and EU over vaccine shortages within the bloc.

Norway suspends Astrazeneca vaccine for another three weeks

Norway has delayed a decision on whether to resume the use of Astrazeneca’s Covid vaccine until 15 April, the Norwegian Institute of Public Health (FHI) said today.

The country joined a list of 17 countries to suspend rollout of the jab last week over reports of blood clots among patients.

Most have since resumed use of the Astrazeneca vaccine following its approval by the European Medicines Agency, which said it was safe and effective. The shot remains on hold in Denmark.

London R rate rises

London’s R rate has risen at the same pace as the UK’s, up from a best estimate of between 0.6 and 0.9 last week to 0.7 and 0.9. It’s an early indication that the decline in coronavirus cases may be slowing within the capital and across the country.

However, the R rate remains below the crucial 1 threshold, meaning the spread of the virus is still shrinking. The next few weeks will be critical, with the Prime Minister adamant that he will prioritise “data not dates” in plans to reopen the country after months of lockdown.

Read more

ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

That said, there has been no huge leap in cases following the reopening of schools and colleges, which scientists warned could push infection rates up once more.

Park chiefs have urged Londoners to comply with social distancing rules when visiting green spaces in the capital this weekend to prevent a spike in cases.

Latest stats

The UK recorded a further 6,397 coronavirus cases in the past 24 hours, including 501 cases in London. It marks a dramatic drop since the start of the year, when infections hit a daily peak of almost 82,000 for the whole country.

More than 29.3m people in Britain have now received at least one dose of a Covid vaccine, including 3m who have received both doses.

US set to overtake UK vaccine rollout

The US is set to overtake the UK in its vaccination rollout after President Joe Biden yesterday doubled his vaccine target, pledging to deliver 200m doses in his first 100 days in office.

The US vaccine rollout has gathered pace in recent weeks with more than 70 per cent of over-65s having received at least one dose of the vaccine. 

Britain currently has the fourth most successful national vaccination programme in the world, having delivered 45 doses per 100 people. But the US is closing in — the country has injected 38 doses per 100 people, with the figure set to rise in the coming weeks.

‘Stay at home’ orders to end on Monday

Don’t forget: the government’s “stay at home” guidance is due to expire on Monday for the first time in 12 weeks.

From 29 March, people will instead be asked to “stay local”, while work from home orders will be softened. Under the current guidance, everyone who “can work from home must do so”. But from Monday, “people should continue to work from home where they can”.

It also means limited contact between different households will be allowed to resume, alongside the reopening of outdoor sports venues. Facilities such as golf courses, tennis courts and swimming pools will all be allowed to open as part of the easing of restrictions, though the rule of six must be adhered to.

Read more

Astrazeneca explores $400bn megadeal with US rival 

AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Politics

Related Topics

  • Coronavirus
  • European Commission
  • Vaccine

Trending Articles

  • As it happened: FTSE 100 drops as oil prices rise after Trump makes Hormuz threat

  • US bond market jitters spark UK economy recession warning

  • Monzo chair makes early exit after boardroom rift

  • Aldi boss wades into supermarket ‘price-gouging’ row

  • New Premier League rules could see £11bn invested into new stadiums

More from Morning Wire

  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Astrazeneca explores $400bn megadeal with US rival 

    Markets
    AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.
  • Astrazeneca share price tumbles on $400bn megamerger talks

    Investing
    Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
  • Astrazeneca and Jaguar Land Rover given power to endorse talented migrants for visas

    Politics
    Jonathan Reynolds addressing the SMMT's annual International Automotive Summit (image courtesy of SMMT)
  • As it happened: FTSE 100 drops as oil prices rise after Trump makes Hormuz threat

    FTSE 100 Live
    Donald Trump speaking at a podium, microphone visible, discussing the Strait of Hormuz
  • As it happened: UK stocks cool after Astrazeneca drags; Trump and Iran clash over peace talks

    FTSE 100 Live
    Donald Trump speaking at a desk, gesturing with hands, wearing a dark suit and red tie.
  • Sweeping job cuts at GSK to fund £400m Cambridge campus

    Pharma
    Modern GSK Cambridge campus buildings with sky bridge, green spaces, and people walking and cycling.
  • Oil price falls but Trump and Iran clash on negotiations claim

    Markets
    Donald Trump smiling in a blue suit and tie with an American flag pin, US flag in background
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook